Concord Biotech Fundamental Analysis
CONCORDBIO
1494.433.30 (2.28%)
Last updated on 18 Sep, 2026 | 15:51 IST
Free Demat with Zero AMC*
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
Concord Biotech Fundamentals
P/E Ratio
56.75
P/B Ratio
7.54
Div. Yield
0.51
Sector P/E
42.35
Sector P/B
3.6
Sec. Div. Yield
0.51
Concord Biotech Fundamentals is currently trading with a P/E Ratio of 56.75, compared to the sector average of 42.35. Its P/B Ratio stands at 7.54, while the sector’s is 3.6. In terms of returns, the stock offers a Dividend Yield of 0.51%, which is than the sector’s 0.51%.
Concord Biotech Score Card
Price
Expensive
Growth
Average
Quality
Good
Management
Good
On its scorecard, Concord Biotech reflects: Price – Expensive, Growth – Average, Quality – Good, and Management – Good. Together, these indicators provide a structured view of the company’s fundamentals.
Open Your Free
Demat Account Now!
AMC for First Year
Auto Square Off Charges
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools

Open Your Free
Demat Account Now!
AMC For First Year
Account Opening Fee
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools
Invest in CONCORDBIO
Account Opening Fee
AMC for 1st Year
Auto Square Off Charges
Call & Trade
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
Or Download Choice FinX App
Invest in CONCORDBIO
Account Opening Fee
AMC for 1st Year
Auto Square Off Charges
Call & Trade